💡 在您使用本产品前请认真阅读说明书,这对您顺利完成实验很有帮助。
|
🏷️ 产品编码
RB9T37014650
|
🧬 中文名称
Concizumab ELISA试剂盒(靶标:)
|
|
📝 英文名称
Concizumab ELISA Kit
| |
|
🔬 应用
ELISA
| |
|
🔢 登录号
P10646
|
🔹 检测方法
Colorimetric
|
|
🔹 灵敏度
0.156 μg/ml
|
🔹 检测范围
0.31-5 μg/mL
|
|
🔹 回收率
80-120%
|
🔹 样本类型
Plasma, Serum
|
|
🔹 检测类型
Quantitative
|
🔹 背景信息
Concizumab (mAb 2021) is a high-affinity, humanized, monoclonal IgG4 antibody (mAb) developed by Novo Nordisk A/S. It was directed against the Kunitz-2 domain of human tissue factor (TF) pathway inhibitor (TFPI), designed to target and selectively block the factor X (FX) a (FXa) binding site of TFPI. As a mAb, concizumab has the advantage of being administered subcutaneously, and exhibits good solubility and stability, allowing administration as a liquid formulation via a ready- and easy-to-use portable pen device. Phase 2 trials of concizumab are ongoing for Haemophilia A and B. On 12 October 2017, orphan designation (EU/3/17/1940) was granted by the European Commission to Novo Nordisk A/S, Denmark, for concizumab for the treatment of haemophilia B.
|
|
🏷️ 别名
Anti-TFPI, NN7415, mab2021, 1312299-39-0
| |
❄️ 稳定性和储存
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 20% prior to the expiration date under appropriate storage condition.
🚚 运输条件
2-8 ℃
⚠️ For Research Use Only.